Cell microencapsulation technology: Towards clinical application

Journal of Controlled Release

Volumn 132, Issue 2, 2008, Pages 76-83

  Murua, Ainhoa ^a   Portero, Aitziber ^a   Orive, Gorka ^a   Hernández, Rosa Ma ^a   de Castro, María ^a   Pedraz, José Luis ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Alginate; Biocompatibility; Cell line; Controlled delivery; Microencapsulation; Polymeric drug delivery system

Indexed keywords

ABS RESINS; BIOCOMPATIBILITY; CELL CULTURE; CELL IMMOBILIZATION; CELL MEMBRANES; CELLS; CYTOLOGY; DRUG DELIVERY; ENCAPSULATION; FUNCTIONAL POLYMERS;

ACTIVE MOLECULES; ALTERNATIVE APPROACHES; CELL ENCAPSULATIONS; CELL LINE; CELL MICROENCAPSULATIONS; CENTRAL NERVOUS SYSTEMS; CLINICAL APPLICATIONS; CONTROLLED DELIVERY; CONTROLLED DRUG DELIVERY SYSTEMS; CURRENT STATES; DELIVERY PROCESSES; DRUG DELIVERY SYSTEMS; DRUG RELEASES; ENCAPSULATED CELLS; IMMUNE SYSTEMS; MICROENCAPSULATION; OPTIMAL TIMES; PHARMACOKINETIC PROPERTIES; POLYMERIC DRUG DELIVERY SYSTEM; POLYMERIC MATRIXES; SEMIPERMEABLE MEMBRANES;

CONTROLLED DRUG DELIVERY;

CELL ENCAPSULATION; CELL LINE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; HUMAN; IMMOBILIZED CELL; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELLS, IMMOBILIZED; CHOROID PLEXUS; DRUG DELIVERY SYSTEMS; GENETIC ENGINEERING; HUMANS; ISLETS OF LANGERHANS; STEM CELLS;

EID: 56349158571     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.08.010     Document Type: Review

References (93)

1. Nair L.S., and Laurencin C.T. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32 (2007) 762-798
2. Karp J.M., and Langer R. Development and therapeutic applications of advanced biomaterials. Curr. Opin. Biotechnol. 18 (2007) 454-459
3. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19 (2001) 1029-1034
4. Sun Q., Chen R.R., Shen Y., Mooney D.J., Rajagopalan S., and Grossman P.M. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm. Res. 22 (2005) 1110-1116
5. Uhrich K.E., Cannizzaro S.M., Langer R.S., and Shakesheff K.M. Polymeric systems for controlled drug release. Chem. Rev. 99 (1999) 3181-3198
6. Champion J.A., Katare Y.K., and Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Release 121 (2007) 3-9
7. Domínguez D.C., Lopes R., and Torres M.L. Proteomics: clinical applications. Clin. Lab. Sci 20 (2007) 245-248
8. Bucht A., Larsson P., Weisbrot L., Thorne C., Pisa P., Smedegard G., Keystone E.C., and Gronberg A. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin. Exp. Immunol. 103 (1996) 357-367
9. Chaterji S., Kwon I.K., and Park K. Smart polymeric gels: Redefining the limits of biomedical devices. Prog. Polym. Sci. 32 (2007) 1083-1122
10. Mata E., Carcaboso A.M., Hernández R.M., Igartua M., Corradin G., and Pedraz J.L. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Vaccine 25 (2007) 877-885
11. Zolnik B.S., and Burgess D.J. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J. Control. Release 127 (2008) 137-145
12. Benny O., Kim S.K., Gvili K., Radzishevsky I.S., Mor A., Verduzco L., Menon L.G., Black P.M., Machluf M., and Carroll R.S. In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. FASEB J. 22 (2008) 488-499
13. Morimoto K., Chono S., Kosai T., Seki T., and Tabata Y. Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs. Drug Deliv. 15 (2008) 113-117
14. Jiang T., Kumbar S.G., Nair L.S., and Laurencin C.T. Biologically active chitosan systems for tissue engineering and regenerative medicine. Curr. Top. Med. Chem. 8 (2008) 354-364
15. Malik D.K., Baboota S., Ahuja A., Hasan S., and Ali J. Recent advances in protein and peptide drug delivery systems. Curr. Drug Deliv. 4 (2007) 141-151
16. Patil S.D., Papadmitrakopoulos F., and Burgess D.J. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J. Control. Release 117 (2007) 68-79
17. de Vos P., Andersson A., Tam S.K., Faas M.M., and Hallé J.P. Advances and barriers in mammalian cell encapsulation for treatment of diabetes. Immunol. Endocr. Metabol. Agents Med. Chem. 6 (2006) 139-153
18. Wang X., Wang W., Ma J., Guo X., Yu X., and Ma X. Proliferation and differentiation of mouse embryonic stem cells in APA microcapsule: a model for studying the interaction between stem cells and their niche. Biotechnol. Prog. 22 (2006) 791-800
19. Thanos C.G., Calafiore R., Basta G., Bintz B.E., Bell W.J., Hudak J., Vasconcellos A., Schneider P., Skinner S.J.M., Geaney M., Tan P., Elliot R.B., Tatnell M., Escobar L., Qian H., Mathiowitz E., and Emerich D.F. Formulating the alginate-polyornithine biocapsule for prolonged stability: evaluation of composition and manufacturing technique. J. Biomed. Mater. Res. A 83 (2007) 216-224
20. Baruch L., and Machluf M. Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability. Biopolymers 82 (2006) 570-579
21. Marsich E., Borgogna M., Donati I., Mozetic P., Strand B.L., Salvador S.G., Vittur F., and Paoletti S. Alginate/lactose-modified chitosan hydrogels: a bioactive biomaterial for chondrocyte encapsulation. J. Biomed. Mater. Res. A 84 (2008) 364-376
22. Donati I., Haug I.J., Scarpa T., Borgogna M., Draget K.I., Skjak-Braek G., and Paoletti S. Synergistic effects in semidilute mixed solutions of alginate and lactose-modified chitosan (chitlac). Biomacromolecules 8 (2007) 957-962
23. Baroli B. Photopolymerization of biomaterials: issues and potentialities in drug delivery, tissue engineering, and cell encapsulation applications. J. Chem. Technol. Biotechnol. 81 (2006) 491-499
24. Ponce S., Orive G., Hernández R., Gascón A.R., Pedraz J.L., de Haan B.J., Faas M.M., Mathieu H.J., and de Vos P. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials 27 (2006) 4831-4839
25. Hill E., Boontheekul T., and Mooney D.J. Regulating activation of transplanted cells controls tissue regeneration. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2494-2499
26. Hill E., Boontheekul T., and Mooney D.J. Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng. 12 (2006) 1295-1304
27. Rokstad A.M., Donati I., Borgogna M., Oberholzer J., Strand B.L., Espevik T., and Skjak-Braek G. Cell-compatible covalently reinforced beads obtained from a chemoenzymatically engineered alginate. Biomaterials 27 (2006) 4726-4737
28. Wilson J.T., Cui W., Sun X., Tucker-Burden C., Weber C.J., and Chaikof E.L. In vivo biocompatibility and stability of a substrate-supported polymerizable membrane-mimetic film. Biomaterials 28 (2007) 609-617
29. Morch Ý.A., Donati I., Strand B.L., and Skjak-Braek G. Molecular engineering as an approach to design new functional properties of alginate. Biomacromolecules 8 (2007) 2809-2814
30. Dusseault J., Leblond F.A., Robitaille R., Jourdan G., Tessier J., Ménard M., Henley N., and Hallé J.P. Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers. Biomaterials 26 (2005) 1515-1522
31. Dusseault J., Langlois G., Meunier M., Ménard M., Perreault C., and Hallé J.P. The effect of covalent cross-links between the membrane components of microcapsules on the dissemination of encapsulated malignant cells. Biomaterials 29 (2008) 917-924
32. Sakai S., and Kawakami K. Synthesis and characterization of both ionically and enzymatically cross-linkable alginate. Acta Biomater. 3 (2007) 495-501
33. 2. Biomacromolecules 8 (2007) 2622-2626
34. Sakai S., Hashimoto I., and Kawakami K. Development of alginate-agarose subsieve-size capsules for subsequent modification with a polyelectrolyte complex membrane. Biochem. Eng. J. 30 (2006) 76-81
35. Miura S., Teramura Y., and Iwata H. Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 27 (2006) 5828-5835
36. Smith A.M., Harris J.J., Shelton R.M., and Perrie Y. 3D culture of bone-derived cells immobilised in alginate following light-triggered gelation. J. Control. Release 119 (2007) 94-101
37. Nicodemus G.D., Villanueva I., and Bryant S.J. Mechanical stimulation of TMJ condylar chondrocytes encapsulated in PEG hydrogels. J. Biomed. Mater. Res. A 83 (2007) 323-331
38. Underhill G.H., Chen A.A., Albrecht D.R., and Bhatia S.N. Assessment of hepatocellular function within PEG hydrogels. Biomaterials 28 (2007) 256-270
39. Gerecht S., Townsend S.A., Pressler H., Zhu H., Nijst C.L.E., Bruggeman J.P., Nichol J.W., and Langer R. A porous photocurable elastomer for cell encapsulation and culture. Biomaterials 28 (2007) 4826-4835
40. Hong Y., Song H., Gong Y., Mao Z., Gao C., and Shen J. Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation. Acta Biomater. 3 (2007) 23-31
41. Chung C., Mesa J., Miller G.J., Randolph M.A., Gill T.J., and Burdick J.A. Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks. Tissue Eng. 12 (2006) 2665-2673
42. Wu T.J., Huang H.H., Hsu Y.M., Lyu S.R., and Wang Y.J. A novel method of encapsulating and cultivating adherent mammalian cells within collagen microcarriers. Biotechnol. Bioeng. 98 (2007) 578-585
43. Consiglio A., Martino S., Dolcetta D., Cusella G., Conese M., Marchesini S., Benaglia G., Wrabetz L., Orlacchio A., Déglon N., Aebischer P., Severini G.M., and Bordignon C. Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts. J. Neurol. Sci. 255 (2007) 7-16
44. Blanco-Bose W.E., Schneider B.L., and Aebischer P. Inducing tolerance to a soluble foreign antigen by encapsulated cell transplants. Mol. Ther. 13 (2006) 447-456
45. Konno T., and Ishihara K. Temporal and spatially controllable cell encapsulation using a water-soluble phospholipid polymer with phenylboronic acid moiety. Biomaterials 28 (2007) 1770-1777
46. Sakai S., Hashimoto I., and Kawakami K. Production of cell enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules. Biotechnol. Bioeng. 99 (2008) 235-243
47. Sakai S., Hashimoto I., and Kawakami K. Agarose-gelatin conjugate for adherent cell-enclosing capsules. Biotechnol. Lett. 29 (2007) 731-735
48. Teramura Y., Kaneda Y., and Iwata H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28 (2007) 4818-4825
49. Krol S., del Guerra S., Grupillo M., Diaspro A., Gliozzi A., and Marchetti P. Multilayer nanoencapsulation: New approach for immune protection of human pancreatic islets. Nano Lett. 6 (2006) 1933-1939
50. Dusseault J., Tam S.K., Ménard M., Polizu S., Jourdan G., Yahia L., and Hallé J.P. Evaluation of alginate purification methods: Effects on polyphenol, endotoxin, and protein contamination. J. Biomed. Mater. Res. A 76 (2006) 243-251
51. Tam S.K., Dusseault J., Polizu S., Ménard M., Hallé J.P., and Yahia L. Impact of residual contamination on the biofunctional properties of purified alginates used for cell encapsulation. Biomaterials 27 (2006) 1296-1305
52. Orive G., Tam S.K., Pedraz J.L., and Hallé J.P. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials 27 (2006) 3691-3700
53. Blasi P., Giovagnoli S., Schoubeen A., Ricci M., Rossi C., Luca G., Basta G., and Calafiore R. Preparation and in vitro and in vivo characterization of composite microcapsules for cell encapsulation. Int. J. Pharm. 324 (2006) 27-36
54. Figliuzzi M., Plati T., Cornolti R., Adobati F., Fagiani A., Rossi L., Remuzzi G., and Remuzzi A. Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomater. 2 (2006) 221-227
55. de Vos P., Faas M.M., Strand B., and Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 27 (2006) 5603-5617
56. Sakai S., Mu C., Kawabata K., Hashimoto I., and Kawakami K. Biocompatibility of subsieve-size capsules versus convetional-size microcapsules. J. Biomed. Mater. Res. A 78 (2006) 394-398
57. de Vos P., de Haan B.J., Kamps J.A.A.M., Faas M.M., and Kitano T. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility?. J. Biomed. Mater. Res. A 80 (2006) 813-819
58. Dufrane D., Van Steenberghe M., Goebbels R.M., Saliez A., Guiot Y., and Gianello P. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27 (2006) 3201-3208
59. Thanos C.G., Bintz B.E., and Emerich D.F. Stability of alginate-polyornithine microcapsules is profoundly dependent on the site of transplantation. J. Biomed. Mater. Res. A 81 (2007) 1-11
60. Orive G., De Castro M., Ponce S., Hernández R.M., Gascón A.R., and Pedraz J.L. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol. Ther. 12 (2005) 283-289
61. Khattak S.F., Chin K.S., Bhatia S.R., and Roberts S.C. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol. Bioeng. 96 (2007) 156-166
62. Barnett B.P., Kraitchman D.L., Lauzon C., Magee P., Walczak W.D., Wilson A., Arepally A., and Bulte J.M.W. Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol. Pharm. 3 (2006) 531-538
63. Black S.P., Constantinidis I., Cui H., Tucker-Burden C., Weber C.J., and Safley S.A. Immune responses to an encapsulated allogeneic islet β-cell line in diabetic NOD mice. Biochem. Biophys. Res. Commun. 340 (2006) 236-243
64. Schneider S., Feilen P.J., Brunnenmeier F., Minnemann T., Zimmermann H., Zimmermann U., and Weber M.M. Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice. Diabetes 54 (2005) 687-693
65. Elliott R.B., Escobar L., Tan P.L.J., Garkavenko O., Calafiore R., Basta P., Vasconcellos A.V., Emerich D.F., Thanos C., and Bambra C. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant. Proc. 37 (2005) 3505-3508
66. Dufrane D., Goebbels R.M., Saliez A., Guiot Y., and Gianello P. Six-Month Survival of microencapsulated pig islets and alginate biocompatibility in primates: Proof of concept. Transplantation 81 (2006) 1345-1353
67. Calafiore R., Basta G., Luca G., Lemmi A., Racanicchi L., Mancuso F., Montanucci M.P., and Brunetti P. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with Type 1 diabetes mellitus. Transplant. Proc. 38 (2006) 1156-1157
68. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Mancuso F., and Brunetti P. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29 (2006) 137-138
69. Emerich D.F., Thanos C.G., Goddard M., Skinner S.J.M., Geany M.S., Bell W.J., Bintz B., Schneider P., Chu Y., Babu R.S., Borlongan C.V., Boekelheide K., Hall S., Bryant B., and Kordower J.H. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol. Dis. 23 (2006) 471-480
70. Jeon Y., Kwak K., Kim S., Kim Y., Lim J., and Baek W. Intrathecal implants of microencapsulated xenogenic chromaffin cells provide a long-term source of analgesic substances. Transplant. Proc. 38 (2006) 3061-3065
71. Riddle K.W., and Mooney D.J. In: Nedović V., and Willaert R. (Eds). Fundamentals of cell immobilisation biotechnology, 1: Materials for cell immobilisation/encapsulation. Series: Focus on biotechnology vol. 8A (2004), Springer 1-19
72. Yasuhara T., and Date I. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application. Cell Transplant 16 (2007) 125-132
73. Sajadi A., Bensadoun J.-C., Schneider B.L., Lo Bianco C., and Aebischer P. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease. Neurobiol. Dis. 22 (2006) 119-129
74. Sieving P.A., Caruso R.C., Tao W., Coleman H.R., Thompson D.J.S., Fullmer K.R., and Bush R.A. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 3896-3901
75. Zhang H., Zhu S.-J., Wang W., Wei Y.-J., and Hu S.-S. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther. 15 (2008) 40-48
76. Nakama H., Ohsugi K., Otsuki T., Date I., Kosuga M., Okuyama T., and Sakuragawa N. Encapsulation cell therapy for mucopolysaccharidosis Type VII using genetically engineered immortalized human amniotic epithelial cells. Tohoku J. Exp. Med. 209 (2006) 23-32
77. Ponce S., Orive G., Hernández R.M., Gascón A.R., Canals J.M., Muñoz M.T., and Pedraz J.L. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J. Control. Release 116 (2006) 28-34
78. Murua A., de Castro M., Orive G., Hernández R.Ma., and Pedraz J.L. In Vitro Characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules. Biomacromolecules 8 (2007) 3302-3307
79. Moran D.M., Koniaris L.G., Jablonski E.M., Cahill P.A., Halberstadt C.R., and McKillop I.H. Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression. Cell Transplant. 15 (2006) 785-798
80. Dvir-Ginzberg M., Konson A., Cohen S., and Agbaria R. Entrapment of retroviral vector producer cells in three-dimensional alginate scaffolds for potential use in cancer gene therapy. J. Biomed. Mater. Res. B Appl. Biomater. 80 (2007) 59-66
81. Abbah S.A., Lu W.W., Chan D., Cheung K.M.C., Liu W.G., Zhao F., Li Z.Y., Leong J.C.Y., and Luk K.D.K. In vitro evaluation of alginate encapsulated adipose-tissue stromal cells for use as injectable bone graft substitute. Biochem. Biophys. Res. Commun. 347 (2006) 185-191
82. Evangelista M.B., Hsiong S.X., Fernandes R., Sampaio P., Kong H.J., Barrias C.C., Salema R., Barbosa M.A., Mooney D.J., and Granja P.L. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 28 (2007) 3644-3655
83. Herrero E.P., del Valle E.M.M., and Galán M.A. Immobilization of mesenchymal stem cells and monocytes in biocompatible microcapsules to cell therapy. Biotechnol. Prog. 23 (2007) 940-945
84. Maguire T., Davidovich A.E., Wallenstein E.J., Novik E., Sharma N., Pedersen H., Androulakis I.P., Schloss R., and Yarmush M. Control of hepatic differentiation via cellular aggregation in an alginate microenvironment. Biotechnol. Bioeng. 98 (2007) 631-644
85. Yim E.K.F., Wan A.C.A., Le Visage C., Liao I.C., and Leong K.W. Proliferation and differentiation of human mesenchymal stem cell encapsulated in polyelectrolyte complexation fibrous scaffold. Biomaterials 27 (2006) 6111-6122
86. Betz M.W., Modi P.C., Caccamese J.F., Coletti D.P., Sauk J.J., and Fisher J.P. Cyclic acetal hydrogel system for bone marrow stromal cell encapsulation and osteodifferentiation. J. Biomed. Mater. Res. A 86 (2008) 662-670
87. Inanç B., Eser Elçin A., Koç A., Baloş K., Parlar A., and Murat Elçin Y. Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres. J. Biomed. Mater. Res. A 82 (2007) 917-926
88. Ferreira L.S., Gerecht S., Fuller J., Shieh H.F., Vunjak-Novakovic G., and Langer R. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28 (2007) 2706-2717
89. Cai X., Lin Y., Ou G., Luo E., Man Y., Yuan Q., and Gong P. Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system. Cell. Biol. Int. 31 (2007) 776-783
90. Kaigler D., Krebsbach P.H., Wang Z., West E.R., Horger K., and Mooney D.J. Transplanted endothelial cells enhance orthotopic bone regeneration. J. Dent. Res. 85 (2006) 633-637
91. Dean S.K., Yulyana Y., Williams G., Sidhu K.S., and Tuch B.E. Differentiation of encapsulated embryonic stem cells after transplantation. Transplantation 82 (2006) 1175-1184
92. Ding H.F., Liu R., Li B.G., Lou J.R., Dai K.R., and Tang T.T. Biologic effect and immunoisolating behavior of BMP-2 gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules. Biochem. Biophys. Res. Commun. 362 (2007) 923-927
93. Babister J.C., Tare R.S., Green D.W., Inglis S., Mann S., and Oreffo R.O.C. Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using "bead-in-bead" polysaccharide capsules. Biomaterials 29 (2008) 58-65